- Home
- CRIS vs WVVI Comparison
CRIS vs WVVI Comparison
Compare CRIS & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- WVVI
- Stock Information
- Founded
- CRIS 2000
- WVVI 1983
- Country
- CRIS United States
- WVVI United States
- Employees
- CRIS N/A
- WVVI N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- WVVI Beverages (Production/Distribution)
- Sector
- CRIS Health Care
- WVVI Consumer Staples
- Exchange
- CRIS Nasdaq
- WVVI Nasdaq
- Market Cap
- CRIS 22.9M
- WVVI 20.4M
- IPO Year
- CRIS 2000
- WVVI N/A
- Fundamental
- Price
- CRIS $1.61
- WVVI $3.71
- Analyst Decision
- CRIS Strong Buy
- WVVI
- Analyst Count
- CRIS 2
- WVVI 0
- Target Price
- CRIS $16.50
- WVVI N/A
- AVG Volume (30 Days)
- CRIS 72.1K
- WVVI 8.5K
- Earning Date
- CRIS 11-13-2025
- WVVI 11-11-2025
- Dividend Yield
- CRIS N/A
- WVVI N/A
- EPS Growth
- CRIS N/A
- WVVI N/A
- EPS
- CRIS N/A
- WVVI N/A
- Revenue
- CRIS $11,405,000.00
- WVVI $38,384,350.00
- Revenue This Year
- CRIS $2.72
- WVVI N/A
- Revenue Next Year
- CRIS $8.27
- WVVI N/A
- P/E Ratio
- CRIS N/A
- WVVI N/A
- Revenue Growth
- CRIS 12.24
- WVVI N/A
- 52 Week Low
- CRIS $1.02
- WVVI $3.17
- 52 Week High
- CRIS $5.27
- WVVI $7.18
- Technical
- Relative Strength Index (RSI)
- CRIS 50.58
- WVVI 46.87
- Support Level
- CRIS $1.49
- WVVI $3.46
- Resistance Level
- CRIS $1.63
- WVVI $4.00
- Average True Range (ATR)
- CRIS 0.10
- WVVI 0.24
- MACD
- CRIS 0.01
- WVVI 0.06
- Stochastic Oscillator
- CRIS 68.87
- WVVI 58.58
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.